PIP4K2B Protein Regulation by NSD1 in HPV-Negative Head and Neck Squamous Cell Carcinoma

Iuliia Topchu1,2, Igor Bychkov1,3, Ekaterina Roshchina1

  • 1Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Division of Hematology/Oncology, Northwestern University, Chicago, IL 60611, USA.

Cancers
|March 28, 2024
PubMed

Insights

This study identifies PIP4K2B as a key downstream target of NSD1 in head and neck squamous cell carcinoma (HNSCC). NSD1 regulates PIP4K2B, impacting cancer cell growth, particularly in laryngeal HNSCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Head and neck squamous cell carcinoma (HNSCC) has a persistent low survival rate.
  • The histone methyltransferase NSD1 is implicated as a potential oncogenic factor in HNSCC.

Purpose of the Study:

  • To investigate the role of NSD1 in HNSCC pathogenesis.
  • To identify downstream targets of NSD1 and their impact on cancer cell growth.

Main Methods:

  • Reverse Phase Protein Array (RPPA) analysis.
  • Validation studies to confirm molecular interactions.
  • In vitro cell growth assays.

Main Results:

  • PIP4K2B identified as a key downstream target of NSD1 in HNSCC.
  • NSD1 positively regulates PIP4K2B transcription via H3K36me2.
  • PIP4K2B depletion downregulates the mTOR pathway, inhibiting cell growth.
  • PIP4K2B overexpression rescues growth in laryngeal HNSCC cells.

Conclusions:

  • PIP4K2B is a novel NSD1-dependent protein in HNSCC.
  • PIP4K2B plays a context-dependent role in HNSCC cell survival.
  • PIP4K2B is a potential therapeutic target for laryngeal cancer.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K